{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:50:12Z","timestamp":1791546612532,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501579"],"award-info":[{"award-number":["81501579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20150702"],"award-info":[{"award-number":["BK20150702"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["2016NJMU105"],"award-info":[{"award-number":["2016NJMU105"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX17_0674"],"award-info":[{"award-number":["KYCX17_0674"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.biomaterials.2018.01.022","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T04:17:30Z","timestamp":1517545050000},"page":"107-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia"],"prefix":"10.1016","volume":"160","author":[{"given":"Qiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gujie","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2018.01.022_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. Children","volume":"372","author":"Jain","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","article-title":"Viral pneumonia","volume":"377","author":"Ruuskanen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib3","first-page":"1","article-title":"Trends in pneumonia and influenza morbidity and mortality","author":"American Lung Association","year":"2015","journal-title":"Am. Lung Assoc. Epidemiol. Stat. Unit Res. Heal. Educ. Div."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib4","first-page":"1","article-title":"Statistical brief # 160 national inpatient hospital Costs\u202f: the most","volume":"31","author":"Torio","year":"2013","journal-title":"Healthc. Cost Util. Proj."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"van der Poll","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.mcna.2011.08.007","article-title":"Community-acquired pneumonia: an unfinished battle","volume":"95","author":"Nair","year":"2011","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jmb.2008.11.042","article-title":"Time-resolved binding of azithromycin to Escherichia coli ribosomes","volume":"385","author":"Petropoulos","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib8","first-page":"442","article-title":"Diagnosis and treatment of community-acquired pneumonia","volume":"73","author":"Lutfiyya","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.2016.0115","article-title":"Antibiotic therapy for adults hospitalized with community-acquired pneumonia a systematic review","volume":"315","author":"Lee","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003495-199651030-00013","article-title":"Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections","volume":"51","author":"Dunn","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1592\/phco.25.4.555.61025","article-title":"Antiinflammatory therapies for cystic fibrosis: past, present, and future","volume":"25","author":"Prescott","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10156-003-0280-4","article-title":"Longterm azithromycin therapy for three patients with chronic lower respiratory tract infections","volume":"10","author":"Kasahara","year":"2004","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJMc1212055","article-title":"U.S. Outpatient antibiotic prescribing, 2010","volume":"368","author":"Hicks","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addr.2014.11.017","article-title":"Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients","volume":"85","author":"Ciofu","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1371\/journal.ppat.1001044","article-title":"The pneumococcal serine-rich repeat protein is an intraspecies bacterial adhesin that promotes bacterial aggregation in\u00a0Vivo and in biofilms","volume":"6","author":"Sanchez","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib16","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1128\/IAI.05186-11","article-title":"The luxs-dependent quorum-sensing system regulates early biofilm formation by streptococcus pneumoniae strain D39","volume":"79","author":"Vidal","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2014.08.013","article-title":"Inhaled antimicrobial therapy - barriers to effective treatment","volume":"85","author":"Weers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib19","article-title":"Pulmonary inhalation aerosols for targeted antibiotics drug delivery","author":"Park","year":"2011","journal-title":"Eur. Pharm. Rev."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib23","series-title":"New York Inf. Healthc","first-page":"253","article-title":"Modern pharmaceutics volume 1 basic principles and systems","author":"Florence","year":"2009"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib24","first-page":"1","article-title":"Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis \u2013 where do we stand?","volume":"5247","author":"Klinger-Strobel","year":"2015","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/jps.21913","article-title":"Feasibility study of pollen-shape drug carriers in dry powder inhalation","volume":"99","author":"Hassan","year":"2010","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2011.04.033","article-title":"Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology","volume":"413","author":"Hassan","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/14787210.2015.1041925","article-title":"Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis","volume":"13","author":"Antoniu","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1208\/s12249-014-0166-z","article-title":"Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size","volume":"15","author":"Du","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2015.12.072","article-title":"Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: spray drying versus spray freeze drying preparation","volume":"499","author":"Yu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14356\/kona.2010005","article-title":"Surface analytical techniques in solid-state particle characterization for predicting performance in dry powder inhalers","volume":"28","author":"Wu","year":"2010","journal-title":"KONA Powder Part. J."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s11095-006-9218-8","article-title":"Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems","volume":"24","author":"Young","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jps.2600791113","article-title":"Effect of hydrophobic coating on the behavior of a hygroscopic aerosol powder in an environment of controlled temperature and relative humidity","volume":"79","author":"Mickey","year":"1990","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib34","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11095-011-0443-4","article-title":"Insulin lung deposition and clearance following technosphere\u00aeinsulin inhalation powder administration","volume":"28","author":"Cassidy","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/mp700096e","article-title":"A\u00a0delineation of diketopiperazine self-assembly processes: understanding the molecular events involved in N\u03b5-(fumaroyl)diketopiperazine of L-Lys (FDKP) interactions","volume":"5","author":"Kaur","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib36","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/193229681000400515","article-title":"Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine","volume":"4","author":"Potocka","year":"2010","journal-title":"J.\u00a0Diabetes Sci. Technol."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib37","series-title":"Catalysis of Diketopiperazine Synthesis","author":"Stevenson","year":"2012"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jamp.2013.1078","article-title":"Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate\/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers","volume":"27","author":"Li","year":"2014","journal-title":"J.\u00a0Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib39","series-title":"U.\u00a0S. Pharmacopeia 38\/NF 33","first-page":"1326","author":"U. S. Pharmacopeial Convention","year":"2016"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib41","series-title":"Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents","author":"Oberg","year":"2016"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cmi.2016.12.022","article-title":"Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae","volume":"23","author":"Ballestero-T\u00e9llez","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib43","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/JCM.00399-07","article-title":"Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds","volume":"45","author":"Espinel-Ingroff","year":"2007","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/AAC.49.3.1046-1054.2005","article-title":"Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in\u00a0vitro and in a mouse pneumonia model","volume":"49","author":"Azoulay-Dupuis","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib45","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/AAC.42.4.862","article-title":"Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model","volume":"42","author":"B\u00e9dos","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib46","first-page":"33","article-title":"Interaction of immunosuppressive agents and human adenovirus infection in mice","volume":"33","author":"Dam Viet Cuong","year":"1986","journal-title":"Acta Microbiol. Hung."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib47","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/iai.4.6.720-724.1971","article-title":"Effect of an immunosuppressive agent, cyclophosphamide, on chronic lactic dehydrogenase virus viremia of mice","volume":"4","author":"DuBuy","year":"1971","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11046-015-9947-5","article-title":"Combination of estrogen and immunosuppressive agents to establish a mouse model of candidiasis with concurrent oral and vaginal mucosal infection","volume":"181","author":"Wang","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.biomaterials.2018.01.022_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i45.40","article-title":"Pulmonary drug delivery systems: recent developments and prospects","volume":"19","author":"Courrier","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1023\/B:PHAM.0000033007.27278.60","article-title":"Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques","volume":"21","author":"Louey","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.powtec.2012.09.023","article-title":"Dry powder inhaler delivery of amorphous drug nanoparticles: effects of the lactose carrier particle shape and size","volume":"233","author":"Kho","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2004.02.002","article-title":"The influence of carrier roughness on adhesion, content uniformity and the in\u00a0vitro deposition of terbutaline sulphate from dry powder inhalers","volume":"275","author":"Flament","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2016.03.052","article-title":"Drug permeation and cellular interaction of amino acid-coated drug combination powders for pulmonary delivery","volume":"504","author":"Vartiainen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2010.02.018","article-title":"Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles","volume":"390","author":"Kawakami","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib55","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1007\/s11095-008-9613-4","article-title":"Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine","volume":"25","author":"Raula","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib56","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1021\/acs.molpharmaceut.5b00062","article-title":"Pulmonary delivery of vancomycin dry powder aerosol to intubated rabbits","volume":"12","author":"Sullivan","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijpharm.2015.10.019","article-title":"Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation","volume":"495","author":"Cuvelier","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib58","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1021\/mp500586p","article-title":"Novel inhaled combination powder containing amorphous colistin and crystalline rifapentine with enhanced antimicrobial activities against planktonic cells and biofilm of Pseudomonas aeruginosa for respiratory infections","volume":"12","author":"Zhou","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/106002809202601014","article-title":"Azithromycin: the first azalide antibiotic","volume":"26","author":"Ballow","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biomaterials.2018.01.022_bib60","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/AAC.44.12.3337-3343.2000","article-title":"Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria","volume":"44","author":"Sindelar","year":"2000","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218300292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218300292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:30:55Z","timestamp":1758904255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218300292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":60,"alternative-id":["S0142961218300292"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.01.022","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}